In 2023, the new European guidelines on severe community-acquired pneumonia, providing
clinical practice recommendations for the management of this life-threatening infection …

The unacceptable high mortality of severe infections and sepsis led over the years to
understand the need for adjunctive immunotherapy to modulate the dysregulated host …

Severe acute respiratory failure (ARF) is a major issue in patients with severe community-
acquired pneumonia (CAP). Standard oxygen therapy is the first-line therapy for ARF in the …

Treatment failure and clinical stability are important outcomes in community-acquired
pneumonia (CAP). It is essential to know the causes and risk factors for treatment failure and …

Despite decades of advances in clinical management protocols and new antibiotics,
pneumonia continues to be a leading cause of morbidity and mortality worldwide. The 2019 …

Objective: This study aimed to investigate the association between serum potassium
variability and 60-day mortality and cardiovascular disease (CVD) in maintenance …

The development and implementation of AI-tools for hospitalization in CAP represent a
transformative approach to improving patient outcomes. The integration of AI into healthcare …

Severe infections induce immune defense mechanisms and initial tissue damage, which
produce an inflammatory neutrophil response. Upon dysregulation of these responses …

Background: Severe community-acquired pneumonia (sCAP) is characterized by severe
symptoms and a poor prognosis, especially with the recent global impact of novel …

We construct and validate a non-invasive clinical scoring model to predict mortality in HIV/TB
patients at end stage of AIDS in China. There were 1,007 HIV/TB patients admitted to Beijing …